NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/06/2021
Back to search
Official data from USPTO
EDGEMONT PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EDGEMONT PHARMACEUTICALS
ST13
US500000077032141Class
5
Filing
77032141
Registration
3900861
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
04/06/2021
Trademark type
Word
Nice classes
5
Filing date
10/30/2006
Registration date
01/04/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2021
Last transaction
04/06/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2010-05-00
First use in commerce
2010-05-00
Drawing code
4
Owner type
16
Owner location
AUSTIN, TX
Examiner
CLAYTON, CHERYL A
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
EDGEMONT PHARMACEUTICALS, LLC
EDGEMONT PHARMACEUTICALS, LLC
Saltel, Douglas A
Representatives
Katherine P. Califa Foley & Lardner LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of central nervous system and endocrine related diseases and disorders
Publications
History of USPTO decisions and trademark events.
63 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/06/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/06/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/06/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
12/22/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/04/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/13/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/13/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/13/2016
E815
TEAS SECTION 8 & 15 RECEIVED
08/08/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/01/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/04/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/24/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/24/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
01/04/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/03/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/02/2010
ALIE
ASSIGNED TO LIE
12/02/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/09/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/15/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/14/2010
EX4G
SOU EXTENSION 4 GRANTED
10/14/2010
IUAF
USE AMENDMENT FILED
10/13/2010
EXT4
SOU EXTENSION 4 FILED
10/13/2010
EEXT
SOU TEAS EXTENSION RECEIVED
10/13/2010
EISU
TEAS STATEMENT OF USE RECEIVED
10/13/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/13/2010
EX3G
SOU EXTENSION 3 GRANTED
03/05/2010
EXT3
SOU EXTENSION 3 FILED
02/19/2010
EEXT
SOU TEAS EXTENSION RECEIVED
02/19/2010
EX2G
SOU EXTENSION 2 GRANTED
10/09/2009
EXT2
SOU EXTENSION 2 FILED
10/07/2009
EEXT
SOU TEAS EXTENSION RECEIVED
10/07/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/10/2009
EX1G
SOU EXTENSION 1 GRANTED
04/13/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/13/2009
EXT1
SOU EXTENSION 1 FILED
03/31/2009
EEXT
SOU TEAS EXTENSION RECEIVED
03/31/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/14/2008
PUBO
PUBLISHED FOR OPPOSITION
07/22/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/18/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/18/2008
NPUB
NOTICE OF PUBLICATION
07/02/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/16/2008
ALIE
ASSIGNED TO LIE
06/14/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/13/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/13/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/15/2008
GNRT
NON-FINAL ACTION E-MAILED
01/15/2008
CNRT
NON-FINAL ACTION WRITTEN
01/15/2008
PETG
PETITION TO REVIVE-GRANTED
12/19/2007
PROA
TEAS PETITION TO REVIVE RECEIVED
12/19/2007
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
10/31/2007
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
10/31/2007
DOCK
ASSIGNED TO EXAMINER
05/23/2007
GNRT
NON-FINAL ACTION E-MAILED
03/16/2007
CNRT
NON-FINAL ACTION WRITTEN
03/16/2007
DOCK
ASSIGNED TO EXAMINER
03/10/2007
MPMK
NOTICE OF PSEUDO MARK MAILED
11/04/2006
NWAP
NEW APPLICATION ENTERED
11/03/2006
Continuous trademark protection
Get notified about every new filing that threatens EDGEMONT PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.